ZIOP

ZIOPHARM Oncology, Inc. (ZIOP) | Rumor.io

ZIOPHARM Oncology

ZIOP

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)—

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about ZIOP?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% new	0% new	0% 0

Jan 26

ZIOPHARM Oncology has rebranded itself as Alaunos Therapeutics.
The company has amended its IND to include four additional TCR-T therapies, bringing the total to 10.
Alaunos is seeking a partner to continue clinical development of its CD19 and BCMA CAR-T assets.

Generated by AI

Sentiment

Of the messages about ZIOP that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	—
Bearish	—	—	—	—

Bullish· Sep 7

$ZIOP has seen a significant increase in trading volume, with 7.9M shares traded, potentially indicating short covering.
Insider buying is a positive sign, with the BOD stepping up to buy stock, and multiple Form 4 filings showing insider purchases.
The stock has strong call option volume, with over 55K calls traded, and a potential breakout above $3.15, with a 200 day MA on daily charts.

Bearish· Aug 10

The company's valuation is low at $437 million, making it an attractive target for potential buyers.
The asset's lack of progress in CD19 RPM CarT trials, despite China's CU/Investigator-led trials showing promising results, raises concerns about its efficacy.
The company's single shot on goal with no real timeline, combined with a new CEO and venture debt, makes it difficult to justify its current price above 50 cents.

Generated by AI

Topics

Of the messages about ZIOP that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	0%
Announcements	—	—	—	100%
Controversies	—	—	—	0%
Earnings	—	—	—	0%
Macro	—	—	—	0%
Technical Analysis	—	—	—	0%

Earnings· May 10

ZIOP misses EPS loss estimates by $0.02.
$ZIOP to host Q1 Earnings Call today at 4:30 PM Eastern, available to stream live or on replay.
ZIOP releases earnings results, missing expectations by $0.02 EPS.

Announcements· Jan 26

ZIOPHARM Oncology, Inc. (ZIOP) has rebranded itself and is now known as Alaunos Therapeutics.
The company has amended its IND to include four additional TCRs, increasing the number of eligible patients who could benefit from its therapies.
Alaunos Therapeutics is seeking a partner for its CD19 and BCMA CAR-T assets to continue clinical development.

Technical Analysis· Feb 24

The user took a long position in ZIOP at $9.86 and sold at $10.06, $10.26, and $10.41.
The user also traded VPCO, but it didn't follow through and was sold for a small loss.
The user has a target price of $11 and $12 for ZIOP.

Generated by AI

Community

Of the messages about ZIOP, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	0%	0%	0%
Newcomers	100%	100%	100%	100%

Regulars· Jan 26

The company has changed its name to Alaunos Therapeutics, and the IND has been amended to include four additional TCRs, increasing the number of eligible patients who could benefit from the therapies.
Alaunos is seeking a partner for its CD19 and BCMA CAR-T assets to continue clinical development, which could potentially make them the best RPM CAR-T money makers in development.
The company's hunTR platform enables the rapid identification of new and proprietary TCRs, which is a key aspect of their TCR-T library and a significant part of their research and development efforts.

Newcomers· Sep 7

Many newcomers are focusing on the significant price increase of $ZIOP, with one post noting a 40% rise.
Some are using $ZIOP as an example, comparing its setup to that of another asset, $TBPH.
A few are looking at $ZIOP as a potential long position, citing its market capitalization, insider activity, and cash reserves as positive factors.

Generated by AI

Also Discussed

Investors talking about ZIOP also mention

#	Name	Attention
1	Alaunos Therapeutics Inc.TCRT	0%new
2	BLCM - Bellicum Pharmaceuticals, Inc.	——
3	RDUS - Radius Recycling, Inc.	——
4	Acadia Pharmaceuticals Inc.ACAD	0%+0
5	Halozyme Therapeutics Inc.HALO	0%0
6	Celldex Therapeutics IncCLDX	0%0
7	XOMA CorporationXOMA	0%0
8	SGMO - Sangamo Therapeutics, Inc.	——
9	NAVB - Navidea Biopharmaceuticals, Inc.	——
10	CorMedix Inc.CRMD	0%+0